Literature DB >> 2178968

Primary intrapulmonary benign schwannoma. A case with ultrastructural and immunohistochemical confirmation.

X Bosch1, J Ramírez, J Font, J A Bombí, J Ferrer, J Vendrell, M Ingelmo.   

Abstract

Neurogenic pulmonary tumours are rare. Neurofibromas are the most common variety and tend to occur in patients with generalized neurofibromatosis, whereas schwannomas arise sporadically in patients who have no evidence of this disorder. A case of solitary benign schwannoma arising in a segmental bronchus is presented, and the published cases reviewed. Microscopically, the tumour had a spindle-shaped cell proliferation with palisade formation in several fields and low cellularity in other areas. The diagnosis was supported by positive immunostaining for S-100 protein and by ultrastructural examination which showed elongated cells surrounded by well-preserved basal lamina and numerous cytoplasmic processes also possessing a basal lamina.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178968

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  3 in total

1.  A strategy of sequential therapy with a bronchoscopic excision and thoracotomy for intra- and extrabronchial wall schwannoma: report of a case.

Authors:  Teruaki Mizobuchi; Toshihiko Iizasa; Akira Iyoda; Sumito Satoh; Takashi Anayama; Kenzo Hiroshima; Takehiko Fujisawa
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  Bronchial schwannomas: clinicopathologic analysis of 7 cases.

Authors:  Yoon Yang Jung; Min Eui Hong; Joungho Han; Tae Sung Kim; Jhingook Kim; Young-Mog Shim; Hojoong Kim
Journal:  Korean J Pathol       Date:  2013-08-26

3.  A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass.

Authors:  Serafeim Chrysikos; Maria Kaponi; Christina Triantafillidou; Theodoros Karampitsakos; Argyrios Tzouvelekis; Maria Anyfanti; Konstantinos Marossis; Marios Konstantinou; Rodoula Tringidou; Demosthenes Bouros; Katerina Dimakou
Journal:  Front Oncol       Date:  2018-01-30       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.